Wall Street Analysts Think 89BIO (ETNB) Could Surge 219.06%: Read This Before Placing a Bet

Core Viewpoint - Shares of 89BIO (ETNB) have increased by 20.6% in the past four weeks, closing at $9.60, with a mean price target of$30.63 indicating a potential upside of 219.1% [1] Price Targets and Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $10.35, where the lowest estimate of$12 suggests a 25% increase, and the highest estimate of $49 indicates a potential surge of 410.4% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction [7] Earnings Estimates - Analysts have shown increasing optimism about ETNB's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [9] - Over the last 30 days, one earnings estimate has increased, leading to a 16.8% rise in the Zacks Consensus Estimate for the current year [10] Zacks Rank - ETNB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11] Conclusion on Price Targets - While the consensus price target may not reliably indicate the extent of ETNB's potential gains, it does provide a useful guide for the direction of price movement [12]